Chlorambucil

MALT Lymphoma

International Extranodal Lymphoma Study Group (IELSG)Small moleculePhase 3Active

BB

69/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 56/ 100
Competitive Position: 95/ 100

Competitive context

32 Active assets in the MALT Lymphoma cohort.

Asset / Sponsor	Phase	Rating
Cyclophosphamide SWOG Cancer Research Network	Phase 2	BBB
Rituximab City of Hope Medical Center	Phase 3	BBB
Dexasone Izidore Lossos, MD	Phase 2	BBB
Fludarabine UNC Lineberger Comprehensive Cancer Center	Phase 2	BB
Vincristine Sulfate SWOG Cancer Research Network	Phase 2	BB

View all 50 →

Same molecule, other indications

Chlorambucil is also rated in:

chronic lymphocytic leukemia/small lymphocytic lymphomaActive

BBB

Indicative · Phase 4

73 / 100

B-cell chronic lymphocytic leukemiaActive

BB

Indicative · Phase 3

71 / 100

lymphomaDormant

BB

Indicative · Phase 3

65 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.